PRME FY 2022 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$117M

Net Income

-$122M

EPS (Diluted)

$-1.46

Cash Flow

Operating Cash Flow

-$132M

Free Cash Flow

-$148M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$360M

Total Liabilities

$44M

Stockholders' Equity

$316M

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$117M	-$84M	-38.0%
Net Income	-$122M	-$165M	+26.3%